Sept. 15, 2021 Price forecast | 2 weeks: -2.95% | 1 month: -5.34% | 3 months: -3.44%


CGEM stock forecast

Our latest prediction for Cullinan Oncology Inc's stock price was made on the Sept. 15, 2021 when the stock price was at 29.00$.

In the short term (2weeks), CGEM's stock price should underperform the market by -2.95%. During that period the price should oscillate between -11.72% and +9.29%.

In the medium term (3months), CGEM's stock price should underperform the market by -3.44%. During that period the price should oscillate between -40.40% and +29.01%.

Create a solid portfolio with CGEM

Add CGEM to your portfolio and optimize it!


About Cullinan Oncology Inc

Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.

At the moment the company generates 19M USD in revenues.

On its last earning announcement, the company reported a loss of -1.24$ per share.

The book value per share is 5.61$

Cullinan Oncology Inc website


Three months stock forecastSept. 15, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
19M - -56M -295.10% -54M -1.24 - - 44M 5.61 -36M - -36M